You are here
ryan.wagner
Originally from Idaho, I have come to UCSF by way of Houston, Texas (Baylor College of Medicine; PhD) and New York City (Icahn School of Medicine at Mount Sinai; Postdoctoral Fellow). My prior research has centered on embryonic stem cell states and ex vivo modeling of mammalian development, specifically on understanding mechanisms of cellular fitness and cell competition in safeguarding the germ line. I am driven professionally by a curiosity in regenerative medicine, gene therapy, and human evolution. In my free time you will likely find me on the tennis court, tweaking a recipe in the kitchen, or planning my next backpacking/camping trip. |
recent publications
Development: sketch for a theory of Oct4.. Vol 23.; 2013. (Curr Biol; vol 23; no 22).
Minireview: the diverse roles of nuclear receptors in the regulation of embryonic stem cell pluripotency.. Vol 27.; 2013. (Mol Endocrinol; vol 27; no 6).
Regulatable in vivo biotinylation expression system in mouse embryonic stem cells.. Vol 8.; 2013. (PLoS ONE; vol 8; no 5).
The E3 ligase c-Cbl regulates dendritic cell activation.. Vol 12.; 2011. (EMBO Rep; vol 12; no 9).
Canonical Wnt/β-catenin regulation of liver receptor homolog-1 mediates pluripotency gene expression.. Vol 28.; 2010. (Stem Cells; vol 28; no 10).
Stem cell approaches for the treatment of type 1 diabetes mellitus.. Vol 156.; 2010. (Transl Res; vol 156; no 3).
OCT4: less is more.. Vol 19.; 2009. (Cell Res; vol 19; no 5).
Evolutionary trace-based peptides identify a novel asymmetric interaction that mediates oligomerization in nuclear receptors.. Vol 280.; 2005. (J Biol Chem; vol 280; no 36).